Filing Details

Accession Number:
0001209191-17-046333
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-07-26 16:52:58
Reporting Period:
2017-07-25
Filing Date:
2017-07-26
Accepted Time:
2017-07-26 16:52:58
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1478069 Contrafect Corp CFRX Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1651911 B Joshua Muntner 30 Fifth Avenue
Apt 12 F
New York NY 10011
Svp Business Development No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, Par Value $0.0001 Per Share Acquisiton 2017-07-25 2,000 $1.24 2,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock, Par Value $0.0001 Per Share Warrants (Right to Buy) Acquisiton 2017-07-25 1,000 $0.01 1,000 $1.55
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
1,000 2017-07-25 2022-07-25 No 4 P Direct